mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors

DSpace Repository

mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors

Author: Schnitzbauer, Andreas A.; Filmann, Natalie; Adam, Rene; Bachellier, Philippe; Bechstein, Wolf O.; Becker, Thomas; Bhoori, Sherrie; Bilbao, Itxarone; Brockmann, Jens; Burra, Patrizia; Chazoullieres, Olivier; Cillo, Umberto; Colledan, Michele; Duvoux, Christoph; Ganten, Tom M.; Gugenheim, Jean; Heise, Michael; van Hoek, Bart; Jamieson, Neville; de Jong, Koert P.; Klein, Christian G.; Klempnauer, Jurgen; Kneteman, Norman; Lerut, Jan; Makisalo, Heikki; Mazzaferro, Vincenzo; Mirza, Darius F.; Nadalin, Silvio; Neuhaus, Peter; Pageaux, George-Philippe; Pinna, Antonio D.; Pirenne, Jaques; Pratschke, Johann; Powel, James; Rentsch, Markus; Rizell, Magnus; Rossi, Giorgio; Rostaing, Lionel; Roy, Andre; Scholz, Tim; Settmacher, Utz; Soliman, Thomas; Strasser, Simone; Soderdahl, Gunnar; Troisi, Roberto I.; Sanchez Turrion, Victor; Schlitt, Hans J.; Geissler, Edward K.
Tübinger Autor(en):
Nadalin, Silvio
Published in: Annals of Surgery (2020), Bd. 272, H. 5, S. 855-862
Verlagsangabe: Lippincott Williams Wilkins
Language: English
Full text: http://dx.doi.org/10.1097/SLA.0000000000004280
ISSN: 1528-1140
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)